Therapeutic Expertise


Characteristics of Rheumatology Clinical Trials

Clinical studies in the field of rheumatology have a long follow-up cycle, and the patients’ medications are mostly complex and varied. Presently, competition in clinical development is gradually increasing and most of the current clinical trials are with biologicals which have a long half-life and long follow-up period.

In these studies, many patients drop out due to intolerable joint pain causing them to change the therapeutic regimen. Additionally, the inclusion and exclusion criteria are strict on requirements regarding the subjects’ prior medication and medical history, therefore the screening failure rate is high.

Proven Track Record of Rheumatology Study Delivery

We are a full-service provider that can partner with you for multiple areas of rheumatology diseases, from early phase trials to global Phase II-VI trials. Tigermed has rapidly accumulated significant project management experience for clinical development in rheumatology, especially in rheumatoid arthritis, and maintained stable relationships with well-known hospital and medical departments.

To cater to the characteristics of various products, Tigermed formulates project risk management plans and progression plans in a targeted manner, and for our approach, we have received appreciation from investigators for aspects including subject recruitment, follow-up, and monitoring.

Our rheumatology team is managed by experienced medical directors and project managers with 7 years’ operational experience in average.


Rheumatology Clinical Trials

Key Indications

  • Rheumatoid arthritis
  • Gout
  • VarSystemic lupus erythematosus (SLE)iety
  • Lupus erythematosus nephropathy
  • Psoriatic arthritis
  • Ankylosing spondylitis

Let's Connect for a Conversation